Lionel Couzi
Overview
Explore the profile of Lionel Couzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
169
Citations
3089
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Noble J, Anglicheau D, Blancho G, Bertrand D, Couzi L, Durrbach A, et al.
Nephrol Ther
. 2025 Mar;
21(1):37-47.
PMID: 40066607
The standard immunosuppressive treatment after organ transplantation typically includes a calcineurin inhibitor (tacrolimus or cyclosporine A), an antimetabolite (mycophenolic acid) or an mTOR inhibitor, and corticosteroids. However, these treatments are...
2.
Charmetant X, Rigault G, Chen C, Kaminski H, Visentin J, Taton B, et al.
Transpl Int
. 2025 Feb;
38:12859.
PMID: 39944220
The generation of donor-specific antibodies (DSA) requires that alloreactive B cells receive help from follicular helper T (T) cells. Recent works have suggested that γδ T cells could contribute to...
3.
Lanot A, Akesson A, Nakano F, Vens C, Bjork J, Nyman U, et al.
BMC Nephrol
. 2025 Jan;
26(1):47.
PMID: 39885391
Background: Creatinine-based estimated glomerular filtration rate (eGFR) equations are widely used in clinical practice but exhibit inherent limitations. On the other side, measuring GFR is time consuming and not available...
4.
Benotmane I, Kasriel N, Masset C, Michard B, Malvezzi P, Giguet B, et al.
Transplantation
. 2025 Jan;
PMID: 39883018
Background: It remains unclear whether physicians should accept transplantation offers for candidates with a positive SARS-CoV-2 reverse transcription polymerase chain reaction test due to the potential risk of severe infection...
5.
Furian L, Heemann U, Bengtsson M, Bestard O, Binet I, Bohmig G, et al.
Transpl Int
. 2025 Jan;
37:13886.
PMID: 39867871
Highly sensitized (HS) patients in need of kidney transplantation (KTx) typically spend a longer time waiting for compatible kidneys, are unlikely to receive an organ offer, and are at increased...
6.
Caillard S, Meyer N, Solis M, Bertrand D, Jaureguy M, Anglicheau D, et al.
Kidney Int
. 2024 Nov;
107(2):338-347.
PMID: 39490986
The MTOR inhibitors have demonstrated antiviral properties, and prior non-randomized studies have suggested they may have a suppressive effect on BKPyV replication. Here, in this randomized, multicenter, controlled trial (BKEVER...
7.
Nakano F, Akesson A, de Boer J, Dedja K, Dhondt R, Haredasht F, et al.
Sci Rep
. 2024 Nov;
14(1):26383.
PMID: 39487227
In clinical practice, the glomerular filtration rate (GFR), a measurement of kidney functioning, is normally calculated using equations, such as the European Kidney Function Consortium (EKFC) equation. Despite being the...
8.
Sablik M, Sannier A, Raynaud M, Goutaudier V, Divard G, Astor B, et al.
N Engl J Med
. 2024 Oct;
392(8):763-776.
PMID: 39450752
Background: The heterogeneous clinical presentation of graft microvascular inflammation poses a major challenge to successful kidney transplantation. The effect of microvascular inflammation on allograft outcomes is unclear. Methods: We conducted...
9.
Cortes Garcia E, Giarraputo A, Racape M, Goutaudier V, Ursule-Dufait C, De La Grange P, et al.
Transplantation
. 2024 Oct;
PMID: 39441708
Background: In kidney transplantation, molecular diagnostics may be a valuable approach to improve the precision of the diagnosis. Using next-generation sequencing (NGS), we aimed to identify clinically relevant archetypes. Methods:...
10.
Chauveau B, Couzi L, Merville P
Transplantation
. 2024 Oct;
109(3):440-453.
PMID: 39436268
The Banff classification is regularly updated to integrate recent advances in the characterization of kidney allograft rejection, gathering novel diagnostic, prognostic, and theragnostic data into a diagnostic and pathogenesis-based framework....